Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Wangbang phase 1
View:
Post by BurningMoney5 on Dec 03, 2021 3:19am

Wangbang phase 1

by the way, the phase 1 started in 2018 I believe so three years and not 7 years ago.
Comment by Pareto8020 on Dec 03, 2021 8:29am
That's even worse - it took them 3-4 years to even start the Phase I then??   Either way you slice it Wanbang is taking their sweet time and it obviously isn't a priority for them based on the snails pace they've been working on SBM's SGLT2 compound.  I would have much rather seen a North Am company run with it - less risk and more exposure.   
Comment by bazooka73 on Dec 03, 2021 9:50am
totally agree. The Wanbang "collaboration" turns out to be  an absolute mess!
Comment by biorun on Dec 03, 2021 10:29am
I am waiting to see how the collaborations on animal therapy before jumping to any conclusions here, while clarity is sought on the human trial underway. That animal market is a much less complex dimension.
Comment by Ticklel1st on Dec 03, 2021 8:07pm
Bio Runs...his is from 2013 and involves animals and it never went anywhere. Why would anyone think anything different today.  VitamFero develops live and attenuated animal vaccines against various infectious diseases, especially against Apicomplexa parasites. VitamFero intends to develop an effective protocol that, beyond their highly proven efficacy, extends the practicability of ...more  
Comment by MirrorWorldMan on Dec 03, 2021 6:31pm
Howie has not been able to license the molecule to anyone else for phase testing and Wanbang took eight years to get nowhere with it.   Generics can arise 20 years post patent and we have already lost 8 of those 20 years. On top of that it  years and millions of dollars to establish endpoint trials trials to make it even remotely possible to be used by any sensible doctor that does not ...more  
Comment by lscfa on Dec 03, 2021 8:02pm
Chinese waiting for the patent to expire.....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities